Health

For more information concerning work and views related to Health, please contact our office.

More on Health

October 2, 2020 Press Release

(Washington, DC) This week, the House of Representatives unanimously passed the Promoting Alzheimer’s Awareness to Prevent Elder Abuse Act to better protect seniors living with Alzheimer’s and dementia. The bill amends the 2017 Elder Abuse Prevention and Prosecution Act to enhance efforts to prevent the abuse and exploitation of individuals with Alzheimer’s disease. Representative Malinowski is a cosponsor of this bill. 

September 25, 2020 Press Release

(Washington, DC) This week, the House passed S. 785, the Commander John Scott Hannon Veterans Mental Health Care Improvement Act, which includes key provisions of a bill led by Representative Tom Malinowski that supports the mental and psychological health of our nation’s hundreds of thousands of veterans that have been diagnosed with a serious mental illness (SMI).

September 23, 2020 Press Release

(Washington, DC) Today, Representatives Tom Malinowski (D-NJ) and Mario Diaz-Balart (R-FL) introduced bipartisan legislation to create an independent, non-partisan commission, closely modeled after the 9/11 Commission that investigated the September 11, 2001 terror attacks, to assess the nation’s preparedness and response to COVID-19 and provide recommendations to improve our country’s readiness for future epidemics and pandemics.  

September 22, 2020 Press Release

(Washington, DC) This week, the House of Representatives unanimously passed the Strengthening America's Strategic National Stockpile Act. This legislation would strengthen and grow our country’s Strategic National Stockpile (SNS), the United States' national repository of critical medical supplies, to better combat future health crises.

September 10, 2020 Press Release

(Washington, DC) Today, Representative Tom Malinowski presented a statement in support of his bill, H.R.8108, the VA Serious Mental Illness Act, to the House Committee on Veterans’ Affairs during a legislative hearing. This important legislation will better support the mental and psychological health of our nation’s veterans. Find his statement below.

August 25, 2020 Press Release

(Washington, DC) Today, Representatives Tom Malinowski (D-NJ) and Neal Dunn, M.D. (R-FL) introduced the bipartisan VA Serious Mental Illness Act, legislation to support the mental and psychological health of our nation’s veterans. Across the United States, hundreds of thousands of veterans have been diagnosed with a serious mental illness (SMI), and the Veterans Affairs (VA) administration must ensure that best practices for treating SMI are shared across its medical facilities.

June 29, 2020 Press Release

(Washington, DC) Today, the House of Representatives passed the Patient Protection and Affordable Care Enhancement Act, legislation that bolsters the Affordable Care Act (ACA) to lower health costs and prescription drug prices. You can find a video of Representative Malinowski’s floor remarks in support of the legislation here.

March 23, 2020 Press Release

(Somerville, NJ) Today, on the 10th Anniversary of the Affordable Care Act (ACA), Congressman Tom Malinowski (D-NJ) called on the U.S. Department of Health and Human Services Secretary Alex Azar to open a Special Enrollment Period in New Jersey to allow uninsured and underinsured residents harmed by COVID-19 related furloughs and layoffs to enroll in health coverage through the federal health insurance exchange. 

March 11, 2020 Press Release

(Washington, DC) Today, Representative Tom Malinowski led a group of 11 of his colleagues in sending a letter to Matt Eyles, President and CEO of America’s Health Insurance Plans, and the eight major American insurance providers, to clarify that patients will continue to have access to life saving prescriptions as the coronavirus epidemic grows.

December 12, 2019 Press Release

(Washington, DC) Today, the House passed H.R. 3 the Elijah E. Cummings Lower Drug Costs Now Act, to help lower the cost of prescription drugs. This bill gives Medicare the ability to negotiate directly with drug companies for the first time, while requiring these lower prices to be transparent and available to those with private insurance. It also creates a new annual $2,000 out-of-pocket limit on prescription drug costs for Medicare beneficiaries.